X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12393) 12393
Publication (921) 921
Book Review (120) 120
Book Chapter (47) 47
Newsletter (16) 16
Dissertation (10) 10
Book / eBook (8) 8
Conference Proceeding (7) 7
Government Document (6) 6
Paper (3) 3
Data Set (2) 2
Magazine Article (2) 2
Newspaper Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7496) 7496
doxorubicin (6982) 6982
index medicus (5796) 5796
animals (5061) 5061
female (3976) 3976
cancer (3767) 3767
pharmacology & pharmacy (3668) 3668
oncology (3451) 3451
doxorubicin - administration & dosage (3244) 3244
chemotherapy (3169) 3169
doxorubicin - pharmacokinetics (2998) 2998
male (2879) 2879
mice (2787) 2787
drug delivery systems (2347) 2347
anthracyclines (2309) 2309
nanoparticles (2211) 2211
cell line, tumor (2154) 2154
doxorubicin - pharmacology (2088) 2088
pharmacokinetics (2043) 2043
drugs (1879) 1879
middle aged (1622) 1622
liposomes (1523) 1523
adult (1400) 1400
aged (1381) 1381
tumors (1367) 1367
drug-delivery (1325) 1325
rats (1317) 1317
doxorubicin - therapeutic use (1302) 1302
vehicles (1246) 1246
chemistry, multidisciplinary (1205) 1205
antibiotics, antineoplastic - pharmacokinetics (1203) 1203
antibiotics, antineoplastic - administration & dosage (1180) 1180
antineoplastic agents - administration & dosage (1179) 1179
doxorubicin - chemistry (1175) 1175
in-vitro (1142) 1142
antineoplastic combined chemotherapy protocols - therapeutic use (1115) 1115
therapy (1107) 1107
analysis (1104) 1104
toxicity (1100) 1100
tissue distribution (1083) 1083
antineoplastic agents - pharmacokinetics (1074) 1074
neoplasms - drug therapy (1073) 1073
drug delivery (1053) 1053
breast neoplasms - drug therapy (1043) 1043
adriamycin (1022) 1022
antineoplastic agents - pharmacology (1021) 1021
breast cancer (1012) 1012
cell survival - drug effects (982) 982
treatment outcome (971) 971
care and treatment (965) 965
nanoscience & nanotechnology (942) 942
paclitaxel (938) 938
dose-response relationship, drug (918) 918
doxorubicin - analogs & derivatives (913) 913
cells (911) 911
drug carriers - chemistry (911) 911
antineoplastic agents - therapeutic use (855) 855
mice, inbred balb c (855) 855
micelles (847) 847
apoptosis (840) 840
in-vivo (837) 837
delivery (816) 816
cytotoxicity (811) 811
p-glycoprotein (802) 802
research (794) 794
doxorubicin - adverse effects (785) 785
nanoparticles - chemistry (771) 771
materials science, biomaterials (759) 759
mice, nude (758) 758
biochemistry & molecular biology (753) 753
tumor (746) 746
breast-cancer (739) 739
drug therapy (736) 736
multidrug-resistance (725) 725
drug resistance (724) 724
health aspects (722) 722
drug carriers (721) 721
polyethylene glycols - chemistry (710) 710
article (702) 702
pegylated liposomal doxorubicin (672) 672
antibiotics, antineoplastic - pharmacology (669) 669
tumor cells, cultured (661) 661
medicine & public health (653) 653
drug delivery systems - methods (647) 647
expression (636) 636
cancer therapies (633) 633
cardiotoxicity (632) 632
particle size (625) 625
antineoplastic agents - chemistry (605) 605
pharmacology/toxicology (586) 586
multidrug resistance (584) 584
xenograft model antitumor assays (580) 580
hydrogen-ion concentration (579) 579
medicine (563) 563
doxorubicin - toxicity (561) 561
apoptosis - drug effects (560) 560
cisplatin (554) 554
solid tumors (554) 554
drug resistance, neoplasm (550) 550
antineoplastic combined chemotherapy protocols - adverse effects (549) 549
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12206) 12206
Japanese (124) 124
Chinese (39) 39
French (32) 32
Russian (20) 20
German (17) 17
Italian (7) 7
Spanish (7) 7
Polish (6) 6
Korean (4) 4
Swedish (2) 2
Bulgarian (1) 1
Czech (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nuclear Medicine and Biology, ISSN 0969-8051, 2009, Volume 36, Issue 5, pp. 515 - 524
Journal Article
Molecular Pharmaceutics, ISSN 1543-8384, 08/2008, Volume 5, Issue 4, pp. 496 - 504
Journal Article
Drugs, ISSN 0012-6667, 06/2000, Volume 59, Issue 6, pp. 1261 - 1277
Neuroblastoma represents one of the most challenging malignancies for treatment decisions because of its unusual biological behaviour. The features include... 
Melphalan, pharmacokinetics | Topoisomerase inhibitors, therapeutic use | Cytarabine, pharmacokinetics | Teniposide, therapeutic use | Fluorouracil, pharmacokinetics | Research and development | Thioguanine, pharmacokinetics | Hydroxycarbamide, pharmacokinetics | Etoposide, pharmacokinetics | Vincristine, pharmacokinetics | Thiotepa, pharmacokinetics | Cisplatin, pharmacokinetics | Doxorubicin, pharmacokinetics | Zilascorb, pharmacokinetics | Procarbazine, pharmacokinetics | Cyclophosphamide, pharmacokinetics | Antineoplastics, therapeutic use | Bleomycin, pharmacokinetics | Busulfan, pharmacokinetics | Dacarbazine, therapeutic use | Ifosfamide, pharmacokinetics | Vinblastine, therapeutic use | Dactinomycin, pharmacokinetics | Lomustine, pharmacokinetics | Mercaptopurine, pharmacokinetics | Carboplatin, pharmacokinetics | Mitoxantrone, pharmacokinetics | Neuroblastoma, treatment | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | NEURO-BLASTOMA | BONE-MARROW TRANSPLANTATION | MESSENGER-RNA | CHROMOSOME 1P | PEDIATRIC-ONCOLOGY-GROUP | METASTATIC NEUROBLASTOMA | CHILDHOOD NEUROBLASTOMA | CLINICAL RELEVANCE | GENE AMPLIFICATION | PHARMACOLOGY & PHARMACY | TOXICOLOGY | MULTIDRUG-RESISTANCE | Prognosis | Humans | Neuroblastoma - drug therapy | Hematopoietic Stem Cell Transplantation | Drug Resistance, Neoplasm | Transplantation, Autologous | Neuroblastoma - mortality
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 8/2016, Volume 78, Issue 2, pp. 353 - 359
Rituximab (MabThera™, Roche) is a chimeric IgG1 monoclonal antibody targeting the CD20 surface antigen on normal and neoplastic B cells. It revolutionized the... 
MabThera | Population pharmacokinetics | DLBCL | Medicine & Public Health | Reditux | Rituximab | Oncology | Cancer Research | Pharmacology/Toxicology | Biosimilar | CHEMOTHERAPY | PHASE-II TRIAL | ANTI-CD20 MONOCLONAL-ANTIBODY | ONCOLOGY | CHOP | PHARMACOLOGY & PHARMACY | ELDERLY-PATIENTS | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Rituximab - pharmacokinetics | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Male | Young Adult | Time Factors | Biosimilar Pharmaceuticals - pharmacokinetics | Vincristine - administration & dosage | Adult | Female | Vincristine - pharmacokinetics | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Biosimilar Pharmaceuticals - administration & dosage | Enzyme-Linked Immunosorbent Assay | Lymphoma, Large B-Cell, Diffuse - pathology | Antibodies, Monoclonal, Murine-Derived - pharmacokinetics | Kaplan-Meier Estimate | Survival Rate | Doxorubicin - pharmacokinetics | Rituximab - administration & dosage | Prednisone - pharmacokinetics | Aged | Cyclophosphamide - pharmacokinetics | Infusions, Intravenous | Nonlinear Dynamics | Developing countries | Lymphomas | B cells | Analysis | Immunoglobulin G | Resveratrol
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 2014, Volume 74, Issue 3, pp. 457 - 463
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2014, Volume 9, Issue 1, p. e82331
Brain cancer is a devastating disease affecting many people worldwide. Effective treatment with chemotherapeutics is limited due to the presence of the... 
MALIGNANT GLIOMA | CELLS | TRANSPORT | MULTIDISCIPLINARY SCIENCES | BARRIER | METASTASES | ADRIAMYCIN | BIODISTRIBUTION | MODEL | CHEMOTHERAPY | PACLITAXEL | Doxorubicin - blood | Glutathione - pharmacokinetics | Doxorubicin - therapeutic use | Capillaries - pathology | Humans | Brain Neoplasms - pathology | Body Weight - drug effects | Polyethylene Glycols - therapeutic use | Drug Delivery Systems | Brain - blood supply | Glutathione - pharmacology | Time Factors | Doxorubicin - analogs & derivatives | Female | Polyethylene Glycols - pharmacology | Glutathione - therapeutic use | Tissue Distribution - drug effects | Glutathione - analogs & derivatives | Endothelial Cells - metabolism | Polyethylene Glycols - pharmacokinetics | Treatment Outcome | Brain Neoplasms - drug therapy | Doxorubicin - pharmacokinetics | Brain - drug effects | Animals | Mice, Nude | Glioblastoma - pathology | Survival Analysis | Brain - pathology | Cell Proliferation - drug effects | Mice | Brain Neoplasms - ultrastructure | Endothelial Cells - pathology | Glioblastoma - drug therapy | Doxorubicin - pharmacology | Glutathione - blood | Drugs | Plasma physics | Drug delivery systems | Anthracyclines | Thiols | Gliomas | Brain tumors | Drug therapy | Cancer | Vehicles | Nuclear medicine | Bioluminescence | Neurosciences | Brain cancer | Glioblastoma | Drug delivery | Metastasis | Cancer therapies | Doxorubicin | Antioxidants | Blood-brain barrier | Inhibition | Xenobiotics | Glutathione | Medical treatment | Pharmacology | Breast cancer | Disease control | Endothelial cells | Studies | Chemotherapy | Brain research | Diffusion barriers | Medical prognosis | Pharmacokinetics | Tumors
Journal Article
Nanomedicine: Nanotechnology, Biology, and Medicine, ISSN 1549-9634, 2015, Volume 12, Issue 5, pp. 1279 - 1290
Journal Article
Molecules, ISSN 1420-3049, 2018, Volume 23, Issue 2, p. 349
Journal Article